HK1223033A1 - 包括交联的透明质酸和环糊精的组合物 - Google Patents
包括交联的透明质酸和环糊精的组合物 Download PDFInfo
- Publication number
- HK1223033A1 HK1223033A1 HK16111351.2A HK16111351A HK1223033A1 HK 1223033 A1 HK1223033 A1 HK 1223033A1 HK 16111351 A HK16111351 A HK 16111351A HK 1223033 A1 HK1223033 A1 HK 1223033A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hyaluronic acid
- medical
- crosslinking agent
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361834952P | 2013-06-14 | 2013-06-14 | |
| US201361834952P | 2013-06-14 | ||
| PCT/EP2014/061942 WO2014198683A2 (en) | 2013-06-14 | 2014-06-09 | Ha with cyclodextrins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1223033A1 true HK1223033A1 (zh) | 2017-07-21 |
Family
ID=50896312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16111351.2A HK1223033A1 (zh) | 2013-06-14 | 2014-06-09 | 包括交联的透明质酸和环糊精的组合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160129134A1 (zh) |
| EP (1) | EP3007708A2 (zh) |
| JP (1) | JP2016524644A (zh) |
| KR (1) | KR20160020509A (zh) |
| CN (1) | CN105451744A (zh) |
| AU (1) | AU2014280303A1 (zh) |
| BR (1) | BR112015031329A2 (zh) |
| CA (1) | CA2914765A1 (zh) |
| HK (1) | HK1223033A1 (zh) |
| MX (1) | MX2015017273A (zh) |
| RU (1) | RU2016100874A (zh) |
| WO (1) | WO2014198683A2 (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014055532A2 (en) * | 2012-10-02 | 2014-04-10 | Allergan, Inc. | Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes |
| WO2015181369A1 (en) * | 2014-05-29 | 2015-12-03 | Galderma S.A. | Cross-linked hyaluronic acid grafted with dextran |
| AU2018240375C1 (en) | 2017-03-22 | 2024-02-01 | Ascendis Pharma A/S | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
| WO2019002369A1 (en) * | 2017-06-28 | 2019-01-03 | Nestlé Skin Health Sa | Glycosaminoglycan hydrogel with grafted dextran or cyclodextrin |
| IT201800007683A1 (it) * | 2018-07-31 | 2020-01-31 | Altergon Sa | Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati |
| CN111494648B (zh) * | 2020-05-14 | 2021-10-22 | 清华大学 | 润滑载药纳米球、药物及其制备方法 |
| CN111850086B (zh) * | 2020-07-29 | 2023-12-29 | 丽珠医药集团股份有限公司 | 注射用伏立康唑的无菌检测方法 |
| KR20220168990A (ko) * | 2021-06-17 | 2022-12-26 | (주)메디톡스 | 히알루론산 가교체, 및 이를 포함하는 충전제 조성물 |
| CN114099710A (zh) * | 2021-12-13 | 2022-03-01 | 中国药科大学 | 一种促进活性物质皮肤滞留的透明质酸-环糊精纳米载体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282717B6 (sk) * | 2000-03-10 | 2002-11-06 | �Stav Experiment�Lnej Farmakol�Gie Sav | Spôsob prípravy ultravysokomolekulových hyalurónanov |
| ITTS20000005A1 (it) * | 2000-07-24 | 2002-01-24 | Cooperativa Ct Ricerch Epoly T | Polisaccaridi coniugati con oligosaccaridi ciclici |
| ES2747978T3 (es) * | 2005-10-03 | 2020-03-12 | Mark A Pinsky | Liposomas no fosfolipídicos que comprenden ácido hialurónico |
| US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| CN102698286B (zh) * | 2012-07-02 | 2013-10-09 | 南开大学 | 一种靶向传递金刚烷顺铂抗癌前药的超分子组装体及制备 |
| WO2014055532A2 (en) * | 2012-10-02 | 2014-04-10 | Allergan, Inc. | Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes |
-
2014
- 2014-06-09 RU RU2016100874A patent/RU2016100874A/ru not_active Application Discontinuation
- 2014-06-09 US US14/898,299 patent/US20160129134A1/en not_active Abandoned
- 2014-06-09 BR BR112015031329A patent/BR112015031329A2/pt not_active IP Right Cessation
- 2014-06-09 CN CN201480042978.2A patent/CN105451744A/zh active Pending
- 2014-06-09 JP JP2016518961A patent/JP2016524644A/ja not_active Withdrawn
- 2014-06-09 WO PCT/EP2014/061942 patent/WO2014198683A2/en not_active Ceased
- 2014-06-09 EP EP14728583.7A patent/EP3007708A2/en not_active Withdrawn
- 2014-06-09 MX MX2015017273A patent/MX2015017273A/es unknown
- 2014-06-09 AU AU2014280303A patent/AU2014280303A1/en not_active Abandoned
- 2014-06-09 KR KR1020167000934A patent/KR20160020509A/ko not_active Withdrawn
- 2014-06-09 HK HK16111351.2A patent/HK1223033A1/zh unknown
- 2014-06-09 CA CA2914765A patent/CA2914765A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014198683A2 (en) | 2014-12-18 |
| AU2014280303A1 (en) | 2016-02-04 |
| RU2016100874A3 (zh) | 2018-05-25 |
| WO2014198683A3 (en) | 2015-02-19 |
| RU2016100874A (ru) | 2017-07-20 |
| CA2914765A1 (en) | 2014-12-18 |
| MX2015017273A (es) | 2016-08-03 |
| EP3007708A2 (en) | 2016-04-20 |
| US20160129134A1 (en) | 2016-05-12 |
| CN105451744A (zh) | 2016-03-30 |
| BR112015031329A2 (pt) | 2017-07-25 |
| KR20160020509A (ko) | 2016-02-23 |
| JP2016524644A (ja) | 2016-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1223033A1 (zh) | 包括交联的透明质酸和环糊精的组合物 | |
| MX2024008464A (es) | Conjugados de ligando-farmaco (adcs) con grupos escindibles enzimaticamente. | |
| MX2016001023A (es) | Formulaciones que contienen dapagliflozina amorfa. | |
| WO2014055532A3 (en) | Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes | |
| HK1215595A1 (zh) | 白細胞介素-10藥物組合物和使用方法 | |
| WO2012112410A3 (en) | Micronized placental tissue compositions and methods for making and using the same | |
| HK1252862A1 (zh) | 结合cd45的抗体分子 | |
| GB201020193D0 (en) | Glucan compositions | |
| HK1216611A1 (zh) | 白蛋白和紫杉醇的納米顆粒組合物 | |
| WO2012065022A3 (en) | Spiro-oxindole mdm2 antagonists | |
| MX2018011053A (es) | Acido hialuronico modificado, metodo para preparar el mismo y usos del mismo. | |
| WO2012163869A3 (en) | Composition comprising an alkoxysilane and a modified starch, and cosmetic use thereof | |
| WO2011098962A3 (fr) | Polysaccharides anioniques fonctionnalisés par au moins deux groupements hydrophobes portés par un spacer au moins trivalent | |
| WO2014194195A3 (en) | Cyclodextrin-based polymers for the therapeutic delivery | |
| WO2014104974A3 (en) | Self-assembling ultrashort peptides modified with bioactive agents by click chemistry | |
| WO2015035342A3 (en) | Factor viii zwitterionic polymer conjugates | |
| LT2920240T (lt) | Chitozano vandeninio tirpalo, chitozano kompozicijos, chitozano aerozolio gamybos būdas, chitozano hidrogelio membranos gamybos būdas ir chitozano ir baltymo biopolimerės medžiagos gamybos būdas | |
| WO2010065329A3 (en) | Nanoparticles for cancer treatment | |
| BRPI0924015A2 (pt) | composição de agente de cura, composição curável e produto termofixo | |
| MX2016007534A (es) | Composicion de gel de acido hialuronico que tiene durabilidad. | |
| WO2010078036A3 (en) | Biocompatible polysaccharide-based hydrogels | |
| EP4233896A3 (en) | Method for preparing an immunogenic lysate, the lysate obtained, dendritic cells loaded with such lysate and a pharmaceutical composition comprising the lysate or the dendritic cells | |
| BR112012001240A2 (pt) | dispersão polimérica aquosa, processo para preparar uma dispersão polimérica aquosa, agente de revestimento na forma de uma composição aquosa, e, uso da dispersão polimérica aquosa | |
| BR112016014275A2 (pt) | Composição, e, método para produção de uma composição | |
| AU2014286128B2 (en) | Human anti-IL-32 antibodies |